According to a study conducted by Kaiser Permanente, COVID-19 patients who receive prompt treatment with Paxlovid have a significantly reduced risk of hospitalization and death….
New research study shows that more exercise is associated with lower rates of hospitalization or death after infection, across diverse demographic groups and chronic conditions….
Kaiser Permanente finds the Pfizer COVID-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months. A research study released on April 22,…
Kaiser Permanente study shows 3 doses of Moderna COVID-19 vaccine highly effective against hospitalization from omicron or delta. New Kaiser Permanente research published on February…
Kaiser Permanente study assessed of Pfizer–BioNTech COVID-19 vaccine effectiveness against infection, hospitalization, and death up to 8 months after vaccination. A Kaiser Permanente study published…
Kaiser Permanente study shows 2-dose Moderna vaccine is highly effective against COVID-19 hospitalization, but protection against delta infection decreases over time. Kaiser Permanente research published…